Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function.

Morrissey J, Hruska K, Guo G, Wang S, Chen Q, Klahr S.

J Am Soc Nephrol. 2002 Jan;13 Suppl 1:S14-21.

2.
3.

Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy.

Morrissey JJ, Ishidoya S, McCracken R, Klahr S.

J Am Soc Nephrol. 1996 Oct;7(10):2202-12.

4.

Renal damage progresses despite improvement of renal function after relief of unilateral ureteral obstruction in adult rats.

Ito K, Chen J, El Chaar M, Stern JM, Seshan SV, Khodadadian JJ, Richardson I, Hyman MJ, Vaughan ED Jr, Poppas DP, Felsen D.

Am J Physiol Renal Physiol. 2004 Dec;287(6):F1283-93. Epub 2004 Aug 24.

PMID:
15328069
5.

[Protection of rosiglitazone against renal interstitial lesion and its mechanism].

Lin Q, Gu Y, Ma J, Lin SY.

Zhonghua Yi Xue Za Zhi. 2005 Jun 22;85(23):1618-24. Chinese.

PMID:
16185530
6.

[Expression of connective tissue growth factor in renal interstitial fibrosis after ureteral obstruction and effects of rapamycin thereupon: experiment with rats].

Sun B, Xing CY, He WC, Wang NN, Yu XB, Zhao XF, Qian J, Yang JW, Liu J, Wang XY.

Zhonghua Yi Xue Za Zhi. 2007 Feb 27;87(8):562-6. Chinese.

PMID:
17459212
7.

Angiotensin-converting enzyme inhibition aggravates renal interstitial injury resulting from partial unilateral ureteral obstruction in the neonatal rat.

Chen CO, Park MH, Forbes MS, Thornhill BA, Kiley SC, Yoo KH, Chevalier RL.

Am J Physiol Renal Physiol. 2007 Mar;292(3):F946-55. Epub 2006 Nov 14.

PMID:
17107943
8.

The effects of rapamycin in the progression of renal fibrosis.

Damião MJ, Bertocchi AP, Monteiro RM, Gonçalves GM, Cenedeze MA, Feitoza CQ, Marques GD, Giannocco G, Mazzali M, Teixeira VP, Dos Reis MA, Pacheco-Silva A, Câmara NO.

Transplant Proc. 2007 Mar;39(2):457-9.

PMID:
17362758
9.

New approaches to delay the progression of chronic renal failure.

Klahr S, Morrissey J, Hruska K, Wang S, Chen Q.

Kidney Int Suppl. 2002 May;(80):23-6. Review.

PMID:
11982808
10.

Bone morphogenetic protein-7: an anti-fibrotic morphogenetic protein with therapeutic importance in renal disease.

Lund RJ, Davies MR, Hruska KA.

Curr Opin Nephrol Hypertens. 2002 Jan;11(1):31-6. Review.

PMID:
11753084
11.

[BMP-7 (Bone morphogenetic protein-7): a future treatment for chronic renal failure?].

Niksic L, Martin PY.

Rev Med Suisse. 2005 Feb 23;1(8):568-70, 572-3. Review. French.

PMID:
15794307
12.
13.
14.

Rosuvastatin preserves renal structure following unilateral ureteric obstruction in the neonatal rat.

Mazzei LJ, García IM, Altamirano L, Docherty NG, Manucha W.

Am J Nephrol. 2012;35(2):103-13. doi: 10.1159/000334935. Epub 2011 Dec 29.

PMID:
22212364
15.

Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction.

Hruska KA, Guo G, Wozniak M, Martin D, Miller S, Liapis H, Loveday K, Klahr S, Sampath TK, Morrissey J.

Am J Physiol Renal Physiol. 2000 Jul;279(1):F130-43.

PMID:
10894795
16.

Prevention of progressive fibrosis in chronic renal diseases: antifibrotic agents.

Negri AL.

J Nephrol. 2004 Jul-Aug;17(4):496-503. Review.

PMID:
15372410
17.

Atorvastatin ameliorates tubulointerstitial fibrosis and protects renal function in chronic partial ureteral obstruction cases.

Fitzgerald JP, Chou SY, Franco I, Mooppan UM, Kim H, Saini R, Gulmi FA.

J Urol. 2009 Oct;182(4 Suppl):1860-8. doi: 10.1016/j.juro.2009.04.086. Epub 2009 Aug 18.

PMID:
19692013
18.

Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy.

Klahr S, Ishidoya S, Morrissey J.

Am J Kidney Dis. 1995 Jul;26(1):141-6. Review.

PMID:
7611245
19.

Does cyclooxygenase-2 inhibitor prevent renal tissue damage in unilateral ureteral obstruction?

Miyajima A, Ito K, Asano T, Seta K, Ueda A, Hayakawa M.

J Urol. 2001 Sep;166(3):1124-9.

PMID:
11490310
20.

Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy.

Wang S, Chen Q, Simon TC, Strebeck F, Chaudhary L, Morrissey J, Liapis H, Klahr S, Hruska KA.

Kidney Int. 2003 Jun;63(6):2037-49.

Supplemental Content

Support Center